The DOJ’s lawsuit against the UGH-Amedisys deal may go nowhere

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why the DOJ's Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere Experts aren't sure what the outcome of the DOJ's recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has focused more on supporting clinicians, while the previous Trump administration favored corporations. Additionally, one expert noted that this case differs from other antitrust lawsuits because it does not seem to focus on a potential price increase. Sponsored Market Trends to Watch for Health Systems and Their Specialty Pharmacies Presented by Shields Health Solutions The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.  Learn More. INVEST 2025: Create Investment Opportunities Be part of the conversation that's transforming healthcare at INVEST in Chicago, 29-30 April, 2025. Meet executives, investors, and innovative startups. Take advantage of the best rate by December 13th. Get Your Ticket at Extreme Early Bird Rate Today

Featured News

5 Healthcare CEOs React to Dr. Oz's CMS Appointment President-Elect Donald Trump nominated celebrity physician Dr. Mehmet Oz to lead CMS. Healthcare leaders have mixed feelings on the news — for instance, one CEO pointed out that Dr. Oz could advance the food-as-medicine movement, and others noted that his appointment may decrease pharmaceutical innovation and access to certain medications. Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin Kura Oncology already had a broad development plan for ziftomenib in leukemias, but the agreement with Kyowa Kirin provides the cash to execute it and a partner to commercialize the drug globally. Ziftomenib is in the same class of medicines as Syndax Pharmaceuticals' Revuforj, which won FDA approval last week. Strategies to Reduce Diagnostic Errors in Patient Care Settings Reducing diagnostic error is a significant part of healthcare organizations' efforts to improve patient outcomes. By using data to recognize vulnerabilities in the diagnostic process, empowering their diagnostic teams and fostering an environment where every team player understands their vital role organizations can proactively correct the potential root causes of diagnostic errors. Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems.

Resources

SPONSORED 5 Top-Rated Electronic Medical Records Software for SMBs This report can help small and midsize businesses compare the five top-rated Electronic Medical Record (EMR) software solutions, and offers insights into: Verified user reviews about EMR software Key features of EMR software Actionable recommendations for SMBs to choose the right software Download Free Guide Now

MedCity News • PO Box 901 • New York, NY unsubscribe